We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRWS icon
14276
CALL
Crown Crafts
CRWS
$32M
-2,700
Closed -$14.1K
CRWS icon
14277
Crown Crafts
CRWS
$32M
-13,924
Closed -$72.8K
CRWS icon
14278
PUT
Crown Crafts
CRWS
$32M
-100
Closed -$523
CSBR icon
14279
CALL
Champions Oncology
CSBR
$68.8M
-3,300
Closed -$17.1K
CSBR icon
14280
Champions Oncology
CSBR
$68.8M
-10,218
Closed -$52.8K
CSBR icon
14281
PUT
Champions Oncology
CSBR
$68.8M
-6,100
Closed -$31.5K
CSHI icon
14282
NEOS Enhanced Income 1-3 Month T-Bill ETF
CSHI
$1.57B
-4,804
Closed -$239K
CTKB icon
14283
PUT
Cytek Biosciences
CTKB
$621M
-100
Closed -$558
CTM icon
14284
Castellum
CTM
$62.4M
-96,128
Closed -$17.9K
CTSO icon
14285
PUT
Cytosorbents Corp
CTSO
$23.3M
-500
Closed -$352
CTXR icon
14286
Citius Pharmaceuticals
CTXR
$20.1M
-7,425
Closed -$125K
CUE icon
14287
Cue Biopharma
CUE
$128M
-2,776
Closed -$60.1K
CULP icon
14288
CALL
Culp Inc
CULP
$43.8M
-100
Closed -$448
CVGW
14289
PUT
DELISTED
Calavo Growers
CVGW
-46,000
Closed -$1.04M
CVIE icon
14290
Calvert International Responsible Index ETF
CVIE
$483M
-11,332
Closed -$639K
CVKD icon
14291
Cadrenal Therapeutics
CVKD
$6.56M
-3,636
Closed -$25.6K
CWK icon
14292
Cushman & Wakefield Ltd
CWK
$3.24B
-58,224
Closed -$734K
CXAI icon
14293
CXApp
CXAI
$19.2M
-33,605
Closed -$69.9K
CXH
14294
DELISTED
MFS Investment Grade Municipal Trust
CXH
-10,641
Closed -$84.1K
CXE
14295
DELISTED
MFS High Income Municipal Trust
CXE
-14,146
Closed -$52.5K
CXSE icon
14296
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$494M
-19,375
Closed -$514K
BGMS
14297
Bio Green Med Solution Inc
BGMS
$5.1M
-51
Closed -$19.9K
DAIO icon
14298
CALL
Data I/O
DAIO
$30.8M
-6,500
Closed -$17.9K
DALI icon
14299
First Trust DorseyWright DALI 1 ETF
DALI
$101M
-46,603
Closed -$1.12M
DAO
14300
PUT
Youdao
DAO
$2.23B
-1,900
Closed -$7.45K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.